IDegLira: combining efficacy, durability, and convenience?

The progressive nature of type 2 diabetes requires the addition of therapies when treatment goals are not achieved. Current guidelines advocate a sequential escalation of therapies based on achievement of agreed HbA1c targets and individual needs. 1 Davies MJ D'Alessio DA Fradkin J et al. Management of hyperglycaemia in type 2 diabetes, 2018. A consensus report by the American Diabetes Association (ADA) and the European Association for the Study...